Health Trials

Tumor Immunity

2

Review clinical trials related to Tumor Immunity. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Malignant Tumor

68Ga-DOTA-dPNE PET/CT imaging was performed on patients with malignant tumors to observe the binding of lesions with the tracer and evaluate the expression of CD73. At the same time, correlation analysis was performed combined with relevant clinical indicators to evaluate the efficacy of 68Ga-DOTA-dPNE in the diagnosis and guidance of malignant tumor patients, and predict the response of targeted therapy.

Participants needed: 50
Trial details
Age: 18-70Biological sex: AllType: InterventionalSponsor: Peking Union Medical College HospitalUpdated: Aug 5, 2025Locations: 1
Eligibility criteria

1: Age: ≥18 years, expected survival ≥12 weeks 2: Without radiotherapy and chemo...

Read more
Status: Recruiting

RFA Plus Carrizumab vs Carrizumab Alone for HCC

The study aims to find whether patients with advanced HCC can get more benefits from RFA +PD-1 immunosuppressant (carrizumab) compared with carrizumab alone, considering with the result of PFS.

Participants needed: 120
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Second Affiliated Hospital, School of Medicine, Zhejiang UniversityUpdated: Jul 8, 2020Locations: 1
Eligibility criteria

Age from 18-75 years [+11]

Have cholangiocarcinoma, mixed type of hepatocarcinoma and fibrolamellar hepatoc... [+15]

Read more